Jenny Qi

Associate

jenny-qi
  • JD, cum laude, University of Michigan Law School, 2013
  • PhD (Molecular and Medical Pharmacology), University of California, Los Angeles, David Geffen School of Medicine, 2010
  • BS (Biochemistry/Psychology), Chinese University of Hong Kong, 2003

Qualifications

  • New York, 2014
  • Chinese (Mandarin)

Jenny Qi

Associate

View the Chinese version. 

Jenny Qi is an associate in Ropes & Gray's private equity transaction group and a registered foreign lawyer in the Hong Kong office. Jenny has extensive experience in private equity and M&A transactions, advising global and regional private equity firms and corporate clients in their cross-border transactions spanning various sectors including technology, health care/life sciences, industrials, consumer and real estate.

Experience

Notable transactions in which Jenny has been involved prior to joining the firm include:

  • Advising a global private equity firm in a variety of acquisition and sale of control or minority interests in the real estate industry across Asia
  • Advising Indospace in its partnership arrangements with GLP with respect to fund restructuring, sale of equity interests in the fund management vehicles and co-investment in IndoSpace’s managed investment vehicles
  • Advising Shandong Ruyi Investment Holding in its acquisition of INVISTA’s Apparel & Advanced Textiles business, including the Lycra brand
  • Advising a global investment bank and Hillhouse Capital in their respective minority investment in a China based dental business 
  • Advising Cathay Fortune Corporation in its public takeover offer for 100% equity interests in Epigenomics AG, a German listed pharmaceutical company and related consortium arrangements 
  • Advising CITIC Capital in its acquisition of minority interests in a real estate business from Vanke
  • Advising Warburg Pincus in its acquisition of minority interests in Trax, a Singapore based information technology company
  • Advising Tencent in its acquisition of minority interests in various businesses in Greater China
  • Advising TPG in the sale of HCP Global Holdings Ltd., a global packaging company, to a private equity buyer 
  • Advising Boyu Capital in its sale of equity interests in a retail business 
  • Advising TPG as a member of an investor consortium in the going-private transaction of Chindex International 
  • Advising Temasek Holdings Private Limited as a member of an investor consortium in the going-private transaction of WuXi Pharma Tech (Cayman) Inc. and subsequent restructuring and re-listing in the PRC, Hong Kong and the US 
Cookie Settings